All In MedTech

FDA Clearance Tracker

Clearance trends: Endocrinology & Diabetes Technology

How many devices FDA lets onto the market, in which specialties, and how long its reviews take. Counts are FDA decisions, not devices sold or used.

Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (newest decision)Source: openFDAMethods & limitations

Decisions per month: Endocrinology & Diabetes Technology

The last 36 months, by pathway. PMA counts are original approvals and panel-track supplements. The newest month is incomplete.

  • 510(k)
  • De Novo
  • PMA
View as table
Month510(k)De NovoPMA
Dec 23300
Jan 24200
Feb 24300
Mar 24400
Apr 24310
May 24400
Jun 24200
Jul 24201
Aug 24400
Sep 24200
Oct 24100
Nov 24300
Dec 24000
Jan 25100
Feb 25100
Mar 25100
Apr 25201
May 25100
Jun 25000
Jul 25100
Aug 25102
Sep 25210
Oct 25100
Nov 25200
Dec 25301
Jan 26200
Feb 26200
Mar 26100
Apr 26400
May 26100
Jun 26500
Jul 26200
Aug 26210
Sep 26600
Oct 26600
Nov 26000

See the Endocrinology & Diabetes Technology decisions

Decisions per year, by specialty

The 6 specialties with the most decisions since 2015. All specialties are in the table below. 2026 is a partial year.

  • Orthopedic Surgery
  • Radiology & Imaging
  • Cardiology
  • General & Plastic Surgery
  • Laboratory Medicine & Pathology
  • Hospital Medicine & Nursing
View as table
YearOrthopedic SurgeryRadiology & ImagingCardiologyGeneral & Plastic SurgeryLaboratory Medicine & PathologyHospital Medicine & Nursing
2015593348411290272182
2016477380392334265215
2017581396405323317237
2018523414397277296213
2019539354373273267199
2020546421370287196193
2021431409330517143368
2022429412354461198401
2023510455405396302271
2024453417361390263201
2025412483372386281194
2026 so far395416403327235131

Every specialty, year by year

510(k) clearances, De Novo grants, original PMA approvals and panel-track PMA supplements, grouped by FDA review panel.

Specialty201520162017201820192020202120222023202420252026*Total
Orthopedic Surgery5934775815235395464314295104534123955,889
Radiology & Imaging3483803964143544214094124554174834164,905
Cardiology4113924053973733703303544053613724034,573
General & Plastic Surgery2903343232772732875174613963903863274,261
Laboratory Medicine & Pathology2722653172962671961431983022632812353,035
Hospital Medicine & Nursing1822152372131991933684012712011941312,805
Dentistry & Oral Surgery2422322272102232592142502482612301952,791
GI, Urology & Nephrology1871792012352132091642042352232652192,534
Neurology & Neurosurgery1331452021741651611751762051992411892,165
Anesthesiology & Respiratory8395871007688706410297100831,045
Obstetrics & Gynecology9575899078797477768494951,006
Physical Medicine & Rehabilitation776958576459828181103113123967
Ophthalmology588073735455375651614340681
Otolaryngology (ENT)524235394331395253384550519

* 2026 is a partial year.

How long FDA takes to decide

Calendar days from the date FDA received the submission to the date it decided. This includes time the clock was stopped while FDA waited for the applicant, so it is longer than FDA's own review-day figures.

PathwayMedian daysMiddle halfBased on
510(k)13382 to 233The 1,000 most recent clearances, decided Jul 24, 2026 to Nov 8, 2026
De Novo326244 to 362The 150 most recent grants, decided 2023 to 2026
PMA (original)342226 to 529The 200 most recent approvals, decided 2020 to 2026

"Middle half" is the range from the 25th to the 75th percentile: half of the decisions in the sample took between those two numbers of days.

510(k) time to decision, by specialty

Median calendar days, from the same sample of recent 510(k) clearances. Specialties with fewer than 15 clearances in the sample are left out.

9 more in this ranking with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.